|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-9-12
|
|
pubmed:abstractText |
Early-stage epithelial ovarian cancer represents a prognostically heterogenous group. We studied prognostic factors in patients treated with adjuvant paclitaxel/carboplatin chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1095-6859
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 Elsevier Inc. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
123
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
37-42
|
|
pubmed:meshHeading |
pubmed-meshheading:21764430-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21764430-Carboplatin,
pubmed-meshheading:21764430-Chemotherapy, Adjuvant,
pubmed-meshheading:21764430-Disease-Free Survival,
pubmed-meshheading:21764430-Female,
pubmed-meshheading:21764430-Humans,
pubmed-meshheading:21764430-Middle Aged,
pubmed-meshheading:21764430-Multivariate Analysis,
pubmed-meshheading:21764430-Neoplasm Staging,
pubmed-meshheading:21764430-Neoplasms, Glandular and Epithelial,
pubmed-meshheading:21764430-Ovarian Neoplasms,
pubmed-meshheading:21764430-Paclitaxel,
pubmed-meshheading:21764430-Prognosis
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: a single institution experience.
|
|
pubmed:affiliation |
Department of Clinical Therapeutics, University of Athens, Athens, Greece. abamias@med.uoa.gr
|
|
pubmed:publicationType |
Journal Article
|
